Real-world drug survival of ixekizumab for psoriasis

被引：9
|
作者：
Lee, Erica B. [1 ]
Pithadia, Deeti J. [2 ]
Reynolds, Kelly A. [3 ]
Reddy, Shivani P. [4 ]
Egeberg, Alexander [5 ]
Wu, Jashin J. [6 ]
机构：
[1] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA
[2] Augusta Univ, Med Coll Georgia, Augusta, GA USA
[3] Univ Cincinnati, Coll Med, Cincinnati, OH USA
[4] Kaiser Permanente Los Angeles Med Ctr, Dept Dermatol, Los Angeles, CA USA
[5] Univ Copenhagen, Herlev & Gentofte Hosp, Dept Dermatol & Allergy, Hellerup, Denmark
[6] Dermatol Res & Educ Fdn, Irvine, CA USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2019年 / 81卷 / 01期
关键词：
PLAQUE PSORIASIS; NONRESPONDERS; EFFICACY; SAFETY; TRIALS;
D O I：
10.1016/j.jaad.2019.01.034
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：270 / 272
页数：4
相关论文
共 50 条
  • [1] Real-world drug survival of guselkumab, ixekizumab and secukinumab for psoriasis
    Iznardo, H.
    Vilarrasa, E.
    Lopez-Ferrer, A.
    Puig, L.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : 660 - 662
  • [2] Drug survival of secukinumab for psoriasis in a real-world setting
    Lee, Erica B.
    Amin, Mina
    Egeberg, Alexander
    Wu, Jashin J.
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2019, 30 (02) : 150 - 151
  • [3] Drug survival of ixekizumab, TNF inhibitors, and other IL-17 inhibitors in real-world patients with psoriasis: The Corrona Psoriasis Registry
    Lockshin, Benjamin
    Cronin, Angel
    Harrison, Ryan W.
    McLean, Robert R.
    Anatale-Tardiff, Laura
    Burge, Russel
    Zhu, Baojin
    Malatestinic, William N.
    Atiya, Bilal
    Murage, Mwangi J.
    Gallo, Gaia
    Strober, Bruce
    Van Voorhees, Abby
    [J]. DERMATOLOGIC THERAPY, 2021, 34 (02)
  • [4] Comment on "Drug survival of apremilast for psoriasis in a real-world setting"
    Santos-Juanes, Jorge
    Velasco, Lucia
    Munguia-Calzada, Pablo
    Lozano, Ana
    Gomez-Diez, Santiago
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (04) : E83 - E84
  • [5] Ixekizumab and Psoriasis in the Real World
    Belinchon Romero, I.
    [J]. ACTAS DERMO-SIFILIOGRAFICAS, 2019, 110 (07): : 520 - 520
  • [6] Real-world drug survival of Brodalumab, in patients with psoriasis switched from Ixekizumab: Results of a single centre retrospective study (BroSwitch)
    Bethlem, Jolijn C.
    Janssens, Jenny A. H. M.
    Tjioe, Milan
    [J]. JEADV CLINICAL PRACTICE, 2023, 2 (03): : 510 - 517
  • [7] Effectiveness and Drug Survival of Ixekizumab and Secukinumab in Patients with Moderate to Severe Plaque Psoriasis: Real-World Data from Bucharest, Romania
    Bucur, Stefana
    Serban, Elena-Daniela
    Ileanu, Bogdan Vasile
    Costache, Raluca Simona
    Nicolescu, Alin Codrut
    Constantin, Traian
    Costache, Daniel Octavian
    Constantin, Maria -Magdalena
    [J]. PSORIASIS-TARGETS AND THERAPY, 2024, 14 : 79 - 86
  • [8] Repy to: "Comment on 'Drug survival of apremilast for psoriasis in a real-world setting'"
    Lee, Erica B.
    Amin, Mina
    Wu, Jashin J.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (04) : E85 - E85
  • [9] Drug survival of apremilast in patients treated for psoriasis in a real-world setting
    Lee, Erica B.
    Amin, Mina
    Wu, Jashin J.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (04) : 760 - 761
  • [10] REAL-WORLD DATA ON THE EFFICACY AND SAFETY OF IXEKIZUMAB IN PATIENTS WITH PLAQUE PSORIASIS
    Stefanaki, Irene
    Rompoti, Natalia
    Panagakis, Pantelis
    Papoutsaki, Marina
    Politou, Maria
    Vavouli, Charitomeni
    Mpefon, Aggeliki
    Fiori, Kousta
    Eleni, Lazou
    Zaimi, Maria
    Koumprentziotis, Ioannis-Alexios
    Zafeiropoulou, Theodora
    Chasapi, Vasiliki
    Stratigos, Alexander
    Nicolaidou, Electra
    [J]. ACTA DERMATO-VENEREOLOGICA, 2024, 104
12345